1. Hakim D, Rabin RC, Rashbau WK. Lawsuits lay bare Sackler family’s role in opioid crisis. New York Times. Apr 2019. https://www.nytimes.com/2019/04/01/health/sacklers-oxycontin-lawsuits.html.
2. Bernstein L, Zezima K. Purdue Pharma, State of Oklahoma research settlement in landmark opioid case. Washington Post. Mar 2019. https://www.washingtonpost.com/national/health-science/purdue-pharma-state-of-oklahoma-reach-settlement-in-landmark-opioid-lawsuit/2019/03/26/69aa5cda-4f11-11e9-a3f7-78b7525a8d5f_story.html.
3. Walters J. “This is blood money”: Tate shuns Sacklers—and others urged to follow. Guardian. Mar 2019. https://www.theguardian.com/artanddesign/2019/mar/24/sackler-money-tate-modern-art-nan-goldin-oxycontin.
4. Meier B. In guilty plea, OxyContin maker to pay $600 million. New York Times. May 2007. https://www.nytimes.com/2007/05/10/business/11drug-web.html.
5. National Academy of Medicine Health and Medicine Division. Evidence-based clinical practice guidelines for prescribing opioids for acute pain. http://nationalacademies.org/hmd/Activities/MentalHealth/GuidelinesforPrescribingOpioids.aspx.